HILLSBORO, Ore.--(BUSINESS WIRE)--Oct 31, 2023--
Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System — an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231031595383/en/
Introducing the Thermo Scientific Meridian EX Semiconductor Fault Isolation System (Photo: Business Wire)
As semiconductor manufacturers adopt more complex architectures to deliver higher performing, energy efficient semiconductors, they are pushing the boundaries of existing failure analysis solutions. Where optical fault isolation tools can still be used for mainstream semiconductors, advanced logic devices now require new solutions to isolate and identify subtle electrical defects which may be fully obscured by metal interconnects on the backside and frontside of the device.
Thermo Fisher’s new Meridian EX System uses an electron beam to probe the device under test. The much smaller wavelength of electron beams versus lasers can help users achieve a 10X spatial resolution improvement compared to commercially available optical laser-based fault isolation solutions. This improvement helps eliminate “cross-talk” from adjacent circuits to deliver more reliable characterization data.
In addition, Meridian EX’s electron beam can enable users to capture dynamic data off metal interconnects, such as power distribution layers, which optical fault isolations systems cannot.
“Chip manufacturers are developing devices with smaller features, new power distribution architectures and new materials, resulting in an increased number of process defects that must be localized and characterized,” said Mohan Iyer, vice president and general manager, semiconductor, at Thermo Fisher Scientific. “As an industry leader in failure analysis workflows and applications, we’re proud to help semiconductor manufacturers address key fault isolation challenges by introducing the Meridian EX and adding electron beam probing technology to Thermo Fisher’s suite of advanced device analysis workflows.”
Features include:
- A new, dedicated electron column design enables precision, through metal probing.
- A new, high-speed beam switching sub-system enables localization of subtle chip defects.
- Industry standard Thermo Scientific Meridian software interface for ease of use and rapid integration into existing lab failure analysis workflows.
Learn more about the Thermo Scientific Meridian EX System: thermofisher.com/meridian-ex
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20231031595383/en/
CONTACT: Media:
Brianna Radicioni
Thermo Fisher Scientific
+1 617-390-3924
Brianna.radicioni@thermofisher.com
KEYWORD: OREGON UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SOFTWARE NANOTECHNOLOGY DATA ANALYTICS HARDWARE ELECTRONIC DESIGN AUTOMATION PROFESSIONAL SERVICES TECHNOLOGY SEMICONDUCTOR
SOURCE: Thermo Fisher
Copyright Business Wire 2023.
PUB: 10/31/2023 08:30 AM/DISC: 10/31/2023 08:33 AM
http://www.businesswire.com/news/home/20231031595383/en
![Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective](/i/c/98db139d-e047-116d-e6cf-4a26032d7ea4.webp)
